Quality Systems

Understand the difference between GMP and cGMP for medical device manufacturing. Covers FDA QMSR (effective Feb 2026), 21 CFR Part 820, ISO 13485:2016 harmonization, cGMP requirements for design controls, production, packaging, labeling, and FDA inspection readiness.

Comprehensive guide to the FDA Humanitarian Device Exemption (HDE) pathway for rare disease medical devices — HUD designation process, HDE application requirements, probable benefit standard, profit restrictions, IRB oversight, post-approval obligations, QMSR implications, and step-by-step instructions.

How to validate and implement vaporized hydrogen peroxide (VHP) sterilization under ISO 22441:2022 — FDA Established Category A recognition, process parameters, validation protocol, material compatibility, and regulatory pathway for medical device manufacturers.

A comprehensive guide to IEC 60601-1-2 EMC compliance for medical electrical equipment — emissions and immunity requirements, Edition 4.1 changes, risk management integration, test plans, environment classification, and regulatory submission.

Complete step-by-step guide to implementing ISO 13485:2016 from scratch. Covers all 8 clauses, documentation hierarchy, certification process (Stage 1 and Stage 2 audits), costs ($5K-$60K+), timeline (6-24 months), notified body selection, and alignment with FDA QMSR effective February 2026.

How to conduct management reviews for medical device companies per ISO 13485 Clause 5.6 and FDA QMSR — required inputs, outputs, frequency, documentation, and common audit findings.

How to prepare, structure, and submit a compliant PSUR under MDR Article 86 — frequency by device class, MDCG 2022-21 template walkthrough, EUDAMED submission for Class III and implantables, benefit-risk analysis, PMS data integration, and the 2025 simplification proposal that may change reporting cadence.

Quality Assurance vs. Quality Control in medical device manufacturing — proactive vs. reactive, process vs. product, responsibilities, tools, org structure, and how QMSR 2026 changes the landscape. Includes FDA 21 CFR 820 and ISO 13485 alignment.

How to build and sustain a quality culture in medical device organizations — FDA QMSR Comment 27 expectations, ISO 13485 Clause 5 management responsibility, behavioral indicators, leadership practices, audit methods, and a practical framework for cultural transformation.

How to conduct quality investigations for medical devices — complaint handling, nonconformance investigation, audit finding root cause analysis, investigation methods, CAPA integration, and regulatory requirements under ISO 13485:2016, FDA 21 CFR 820, and EU MDR.

How to build a quality KPI framework for medical device companies — CAPA effectiveness, first pass yield, complaint rates, design control metrics, and cost of quality. Fully aligned with ISO 13485:2016 and FDA QMSR 2026 requirements.

How to write a quality manual that satisfies ISO 13485:2016 Clause 4.2.2 — the four mandatory elements, documentation structure, FDA QMSR considerations, common mistakes, and a detailed template outline.

Complete guide to root cause analysis for medical device companies — 5 Whys, fishbone diagrams, fault tree analysis, Pareto charts, CAPA integration, and common mistakes that lead to FDA 483 observations.

How to build and maintain a requirements traceability matrix for medical devices — linking user needs, design inputs, outputs, risk controls, verification, and validation under FDA 21 CFR 820.30, ISO 13485:2016, IEC 62304, and EU MDR.

Complete guide to training management in medical device QMS — ISO 13485 Clause 6.2 requirements, FDA QMSR expectations, effectiveness evaluation methods, electronic training systems, and audit-readiness best practices.

Complete guide to FDA 21 CFR Part 11 for medical device companies — electronic records, electronic signatures, audit trails, system validation, CSA guidance, and how Part 11 connects to ISO 13485 and the new QMSR.

The complete guide to document control for medical device companies — ISO 13485 clause 4.2 requirements, FDA 21 CFR 820.40, document lifecycle management, eQMS implementation, change control, version control, and common audit findings.

The complete guide to nonconformance management in medical device manufacturing — FDA 21 CFR 820.90, ISO 13485 clause 8.3, NCR writing, disposition options, Material Review Board, escalation to CAPA, root cause analysis, and common audit findings.

Comprehensive guide to FDA and EU MDR regulations for reprocessing single-use medical devices — covering 510(k)/PMA requirements, Article 17, Common Specifications, cost savings, and the 2026 EU amendment.

How to budget for ISO 13485 certification in 2026 — consulting fees (offsite vs onsite), surveillance and recertification costs, what auditors look for, how to choose a certification body, and ISO 13485 vs ISO 9001 for medical device companies. Plus the impact of FDA's QMSR.